| Health Atlast Long Beach | |
|
2221 Palo Verde Ave #1j, Long Beach, CA 90815-9081 | |
| (562) 795-7007 | |
| Not Available |
| Full Name | Health Atlast Long Beach |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Physical Rehabilitation |
| Location | 2221 Palo Verde Ave #1j, Long Beach, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144716663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0019X | Occupational Therapist - Physical Rehabilitation | (* (Not Available)) | Primary |
| Provider Name | Paul J Newton |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1649396052 PECOS PAC ID: 4587702782 Enrollment ID: I20091109000492 |
News Archive
The analysis takes just a few minutes and the doctor knows straight-away whether there are any pathogens in the blood. An improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.
The American Society of Clinical Oncology is developing a system to rate drugs for advanced cancer based on their likely benefits and side effects, as well as on their price. Meanwhile, better long-term care is urged for the millions who survive the disease and a report details how drugmakers are tailoring treatments to individuals' genetic makeups even though that may affect only small numbers of people.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).
› Verified 3 days ago
| Provider Name | Gary S Rinzler |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1154409811 PECOS PAC ID: 4183809023 Enrollment ID: I20110419000838 |
News Archive
The analysis takes just a few minutes and the doctor knows straight-away whether there are any pathogens in the blood. An improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.
The American Society of Clinical Oncology is developing a system to rate drugs for advanced cancer based on their likely benefits and side effects, as well as on their price. Meanwhile, better long-term care is urged for the millions who survive the disease and a report details how drugmakers are tailoring treatments to individuals' genetic makeups even though that may affect only small numbers of people.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).
› Verified 3 days ago
| Provider Name | Michael N Truong |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1376834143 PECOS PAC ID: 3173837713 Enrollment ID: I20150727002683 |
News Archive
The analysis takes just a few minutes and the doctor knows straight-away whether there are any pathogens in the blood. An improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.
The American Society of Clinical Oncology is developing a system to rate drugs for advanced cancer based on their likely benefits and side effects, as well as on their price. Meanwhile, better long-term care is urged for the millions who survive the disease and a report details how drugmakers are tailoring treatments to individuals' genetic makeups even though that may affect only small numbers of people.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Health Atlast Long Beach 2221 Palo Verde Ave Ste 1j, Long Beach, CA 90815-2360 Ph: (562) 795-7007 | Health Atlast Long Beach 2221 Palo Verde Ave #1j, Long Beach, CA 90815-9081 Ph: (562) 795-7007 |
News Archive
The analysis takes just a few minutes and the doctor knows straight-away whether there are any pathogens in the blood. An improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.
The American Society of Clinical Oncology is developing a system to rate drugs for advanced cancer based on their likely benefits and side effects, as well as on their price. Meanwhile, better long-term care is urged for the millions who survive the disease and a report details how drugmakers are tailoring treatments to individuals' genetic makeups even though that may affect only small numbers of people.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).
› Verified 3 days ago
Sara Aileen Harrison, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 Hughes Way # 100, Long Beach, CA 90810 Phone: 323-397-8729 | |
Uchenna C Ebiringah, MSOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5901 E 7th St, Long Beach, CA 90822 Phone: 708-904-1707 | |
Miss Renee Leigh Frohn, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5901 E 7th St, Long Beach Va Hospital, Long Beach, CA 90822 Phone: 562-826-8000 | |
Danielle Ann, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2888 Long Beach Blvd Ste 405, Long Beach, CA 90806 Phone: 562-595-4489 | |
Kristy P Nguyen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 Termino Ave, Long Beach, CA 90804 Phone: 562-433-6791 | |
Therapro Inc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7031 Seawind Dr, Long Beach, CA 90803 Phone: 562-799-0939 Fax: 562-799-0933 | |
Orland Garcia, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2888 Long Beach Blvd, #405, Long Beach, CA 90806 Phone: 562-595-4489 Fax: 562-595-4063 |